scholarly journals Assessment of anxiety and depression in patients with burning mouth syndrome: A clinical trial

2012 ◽  
Vol 3 (1) ◽  
pp. 36
Author(s):  
Rohit Malik ◽  
Deepankar Misra ◽  
Akansha Misra ◽  
Sapna Panjwani ◽  
Sumit Goel
2021 ◽  
Vol 67 (3) ◽  
pp. 150-155
Author(s):  
Raluca Ema Pîrvu ◽  
◽  
Ioanina Părlătescu ◽  
Șerban Țovaru ◽  
Cosmin Dugan ◽  
...  

This research gives a scientific framework for burning mouth syndrome(BMS) etiology and diagnostic approach in clinical dental and medical practice. BMS-like symptoms can be induced by systemic diseases such as diabetes, gastrointestinal, endocrine disorders, allergy etc. or by local oral cavity conditions as candidiasis or geographic tongue or odontogenic causes. Because the etiology of BMS is multifactorial, treatment can only be distinctive, and is aimed at relieving symptoms. The complexity of BMS symptoms and associated psychosocial infirmities, anxiety and depression raise the need for a multidisciplinary and individualised approach.


2017 ◽  
Vol 23 (2) ◽  
pp. 126-134 ◽  
Author(s):  
Faraína Rodrigues Vasconcelos Franco ◽  
Luciano Alberto Castro ◽  
Maria Cristina Borsatto ◽  
Erika Aparecida Silveira ◽  
Rejane Faria Ribeiro-Rotta

Cephalalgia ◽  
2016 ◽  
Vol 37 (3) ◽  
pp. 265-277 ◽  
Author(s):  
Federica Galli ◽  
Giovanni Lodi ◽  
Andrea Sardella ◽  
Elena Vegni

Background Burning mouth syndrome (BMS) is a chronic medical condition characterised by hot, painful sensations in the lips, oral mucosa, and/or tongue mucosa. On examination, these appear healthy, and organic causes for the pain cannot be found. Several studies have yielded scant evidence of the involvement of psychological and/or psychopathological factors, and several have outlined a model for the classification of BMS. Aim This review aims to provide a systematic review of research examining the psychological, psychiatric, and/or personality factors linked to BMS. Findings Fourteen controlled studies conducted between 2000 and the present were selected based on stringent inclusion/exclusion criteria. All studies but one reported at least some evidence for the involvement of psychological factors in BMS. Anxiety and depression were the most common and the most frequently studied psychopathological disorders among BMS patients. Discussion and conclusion Anxiety and depression play critical roles in this condition. Evidence on the role of personality characteristics of BMS patients has also been produced by a few studies. Further studies on the role of specific psychological factors in BMS are warranted, but the importance of a multidisciplinary approach (medical and psychological) to BMS is no matter of discussion.


2018 ◽  
Vol 33 (6) ◽  
pp. 1255-1262 ◽  
Author(s):  
Natália Guimarães Barbosa ◽  
Amanda Katarinny Goes Gonzaga ◽  
Luzia Leiros de Sena Fernandes ◽  
Aldilane Gonçalves da Fonseca ◽  
Salomão Israel Monteiro Lourenço Queiroz ◽  
...  

Author(s):  
B. Palacios-Sanchez ◽  
LA. Moreno-Lopez ◽  
R. Cerero-Lapiedra ◽  
S. Llamas-Martinez ◽  
G. Esparza-Gomez

2012 ◽  
Vol 113 (3) ◽  
pp. 373-377 ◽  
Author(s):  
Juliana Cassol Spanemberg ◽  
Karen Cherubini ◽  
Maria Antonia Zancanaro de Figueiredo ◽  
Ana Paula Neutzling Gomes ◽  
Maria Martha Campos ◽  
...  

2018 ◽  
Vol 32 (2) ◽  
pp. 178-188 ◽  
Author(s):  
Elena Varoni ◽  
Alfredo Lo Faro ◽  
Giovanni Lodi ◽  
Antonio Carrassi ◽  
Marcello Iriti ◽  
...  

Pain Medicine ◽  
2020 ◽  
Author(s):  
Alessio Gambino ◽  
Marco Cabras ◽  
Evangelos Panagiotakos ◽  
Federico Calvo ◽  
Alessandra Macciotta ◽  
...  

Abstract Objective To evaluate the use of a Cannabis sativa oil in the management of patients diagnosed with primary burning mouth syndrome (BMS). Design Prospective, open-label, single-arm pilot study. Setting University hospital. Subjects Seventeen patients with diagnosed BMS were included. Methods Subjects were treated for 4 weeks with a full cannabis plant extract, which was prepared from standardized plant material (cannabis flos) in specialized pharmacies by means of Romano-Hazekamp extraction and was diluted in oil (1 g of cannabis in 10 g of olive oil). The primary outcome was the change in pain intensity (assessed by the visual analog scale, Present Pain Intensity scale, McGill Pain Questionnaire, and Oral Health Impact Profiles) at the end of the protocol and during the succeeding 24 weeks; the neuropathic pain was also investigated with a specific interview questionnaire (DN4-interview [Douleur Neuropathique en 4 Questions]). Levels of anxiety and depression were considered as secondary outcomes, together with reported adverse events due to the specified treatment. Results Subjects showed a statistically significant improvement over time in terms of a clinical remission of the oral symptoms. Levels of anxiety and depression also changed statistically, displaying a favorable improvement. No serious reactions were detailed. None of the patients had to stop the treatment due to adverse events. Conclusions In this pilot evaluation, the C. sativa oil provided was effective and well tolerated in patients with primary BMS. Further bigger and properly defined randomized controlled trials, with different therapeutic approaches or placebo control, are needed, however.


Sign in / Sign up

Export Citation Format

Share Document